Immunocore Balance Sheet
NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Immunocore financial position
At the end of fiscal 2025, Immunocore reported total assets of $1.07 billion, up 5.7% from a year earlier against total liabilities of $686.2 million. Shareholders' equity stood at $381.0 million, or 35.7% of assets. The company held $467.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.04, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Immunocore balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 |
|---|---|---|---|---|---|
| Cash & Equivalents | 467.71M | 455.73M | 442.63M | 402.47M | 321.08M |
| Short-Term Investments | 396.44M | 364.64M | 0 | — | — |
| Receivables | — | 63.01M | 52.09M | 33.58M | — |
| Inventory | 6.74M | 5.45M | 4.50M | 692.00K | — |
| Total Current Assets | 996.74M | 929.86M | 528.82M | 473.98M | — |
| Property, Plant & Equipment | 11.46M | 10.09M | 9.21M | 7.83M | — |
| Total Assets | 1.07B | 1.01B | 597.00M | 526.76M | — |
| Accounts Payable | 24.36M | 25.10M | 17.80M | 14.45M | — |
| Total Current Liabilities | 246.70M | 212.18M | 139.02M | 100.83M | — |
| Total Liabilities | 686.24M | 648.79M | 228.16M | 187.86M | — |
| Shareholders' Equity | 381.03M | 360.72M | 368.84M | 338.90M | 233.71M |
| Retained Earnings | -831.27M | -795.76M | -744.67M | -689.39M | — |
| Net Cash (Debt) | 864.15M | 820.38M | 442.63M | 402.47M | 321.08M |
| Shares Outstanding | 50.69M | 50.06M | 49.73M | 48.09M | 212.24K |
This table shows 5 annual periods of Immunocore's balance sheet, from FY 2025 back to FY 2021, across 14 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IMCR's reporting calendar. What is a balance sheet?